Global and United States Non-invasive Parenteral Screening Market Report & Forecast 2023-2028

Report ID: 1823513 | Published Date: Jan 2025 | No. of Page: 95 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Non-invasive Parenteral Screening Revenue in Non-invasive Parenteral Screening Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Non-invasive Parenteral Screening Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Non-invasive Parenteral Screening Market Size for the Year 2017-2028
        1.2.2 Global Non-invasive Parenteral Screening Market Size for the Year 2017-2028
    1.3 Non-invasive Parenteral Screening Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Non-invasive Parenteral Screening in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Non-invasive Parenteral Screening Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Non-invasive Parenteral Screening Market Dynamics
        1.4.1 Non-invasive Parenteral Screening Industry Trends
        1.4.2 Non-invasive Parenteral Screening Market Drivers
        1.4.3 Non-invasive Parenteral Screening Market Challenges
        1.4.4 Non-invasive Parenteral Screening Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Non-invasive Parenteral Screening by Type
    2.1 Non-invasive Parenteral Screening Market Segment by Type
        2.1.1 Instruments
        2.1.2 Consumables
    2.2 Global Non-invasive Parenteral Screening Market Size by Type (2017, 2022 & 2028)
    2.3 Global Non-invasive Parenteral Screening Market Size by Type (2017-2028)
    2.4 United States Non-invasive Parenteral Screening Market Size by Type (2017, 2022 & 2028)
    2.5 United States Non-invasive Parenteral Screening Market Size by Type (2017-2028)
3 Non-invasive Parenteral Screening by Application
    3.1 Non-invasive Parenteral Screening Market Segment by Application
        3.1.1 Diagnostic Laboratories
        3.1.2 Hospitals
    3.2 Global Non-invasive Parenteral Screening Market Size by Application (2017, 2022 & 2028)
    3.3 Global Non-invasive Parenteral Screening Market Size by Application (2017-2028)
    3.4 United States Non-invasive Parenteral Screening Market Size by Application (2017, 2022 & 2028)
    3.5 United States Non-invasive Parenteral Screening Market Size by Application (2017-2028)
4 Global Non-invasive Parenteral Screening Competitor Landscape by Company
    4.1 Global Non-invasive Parenteral Screening Market Size by Company
        4.1.1 Top Global Non-invasive Parenteral Screening Companies Ranked by Revenue (2021)
        4.1.2 Global Non-invasive Parenteral Screening Revenue by Player (2017-2022)
    4.2 Global Non-invasive Parenteral Screening Concentration Ratio (CR)
        4.2.1 Non-invasive Parenteral Screening Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Non-invasive Parenteral Screening in 2021
        4.2.3 Global Non-invasive Parenteral Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Non-invasive Parenteral Screening Headquarters, Revenue in Non-invasive Parenteral Screening Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Non-invasive Parenteral Screening Headquarters and Area Served
        4.3.2 Global Non-invasive Parenteral Screening Companies Revenue in Non-invasive Parenteral Screening Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Non-invasive Parenteral Screening Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Non-invasive Parenteral Screening Market Size by Company
        4.5.1 Top Non-invasive Parenteral Screening Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Non-invasive Parenteral Screening Revenue by Players (2020, 2021 & 2022)
5 Global Non-invasive Parenteral Screening Market Size by Region
    5.1 Global Non-invasive Parenteral Screening Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Non-invasive Parenteral Screening Market Size by Region (2017-2028)
        5.2.1 Global Non-invasive Parenteral Screening Market Size by Region: 2017-2022
        5.2.2 Global Non-invasive Parenteral Screening Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Non-invasive Parenteral Screening Market Size YoY Growth 2017-2028
        6.1.2 North America Non-invasive Parenteral Screening Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Non-invasive Parenteral Screening Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Non-invasive Parenteral Screening Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Non-invasive Parenteral Screening Market Size YoY Growth 2017-2028
        6.3.2 Europe Non-invasive Parenteral Screening Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Non-invasive Parenteral Screening Market Size YoY Growth 2017-2028
        6.4.2 Latin America Non-invasive Parenteral Screening Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Non-invasive Parenteral Screening Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Non-invasive Parenteral Screening Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 GE Healthcare
        7.1.1 GE Healthcare Company Details
        7.1.2 GE Healthcare Business Overview
        7.1.3 GE Healthcare Non-invasive Parenteral Screening Introduction
        7.1.4 GE Healthcare Revenue in Non-invasive Parenteral Screening Business (2017-2022)
        7.1.5 GE Healthcare Recent Development
    7.2 Philips
        7.2.1 Philips Company Details
        7.2.2 Philips Business Overview
        7.2.3 Philips Non-invasive Parenteral Screening Introduction
        7.2.4 Philips Revenue in Non-invasive Parenteral Screening Business (2017-2022)
        7.2.5 Philips Recent Development
    7.3 Illumina
        7.3.1 Illumina Company Details
        7.3.2 Illumina Business Overview
        7.3.3 Illumina Non-invasive Parenteral Screening Introduction
        7.3.4 Illumina Revenue in Non-invasive Parenteral Screening Business (2017-2022)
        7.3.5 Illumina Recent Development
    7.4 Thermo Fisher Scientific
        7.4.1 Thermo Fisher Scientific Company Details
        7.4.2 Thermo Fisher Scientific Business Overview
        7.4.3 Thermo Fisher Scientific Non-invasive Parenteral Screening Introduction
        7.4.4 Thermo Fisher Scientific Revenue in Non-invasive Parenteral Screening Business (2017-2022)
        7.4.5 Thermo Fisher Scientific Recent Development
    7.5 Roche
        7.5.1 Roche Company Details
        7.5.2 Roche Business Overview
        7.5.3 Roche Non-invasive Parenteral Screening Introduction
        7.5.4 Roche Revenue in Non-invasive Parenteral Screening Business (2017-2022)
        7.5.5 Roche Recent Development
    7.6 PacBio
        7.6.1 PacBio Company Details
        7.6.2 PacBio Business Overview
        7.6.3 PacBio Non-invasive Parenteral Screening Introduction
        7.6.4 PacBio Revenue in Non-invasive Parenteral Screening Business (2017-2022)
        7.6.5 PacBio Recent Development
    7.7 Perkinelmer
        7.7.1 Perkinelmer Company Details
        7.7.2 Perkinelmer Business Overview
        7.7.3 Perkinelmer Non-invasive Parenteral Screening Introduction
        7.7.4 Perkinelmer Revenue in Non-invasive Parenteral Screening Business (2017-2022)
        7.7.5 Perkinelmer Recent Development
    7.8 Qiagen
        7.8.1 Qiagen Company Details
        7.8.2 Qiagen Business Overview
        7.8.3 Qiagen Non-invasive Parenteral Screening Introduction
        7.8.4 Qiagen Revenue in Non-invasive Parenteral Screening Business (2017-2022)
        7.8.5 Qiagen Recent Development
    7.9 Agilent Technologies
        7.9.1 Agilent Technologies Company Details
        7.9.2 Agilent Technologies Business Overview
        7.9.3 Agilent Technologies Non-invasive Parenteral Screening Introduction
        7.9.4 Agilent Technologies Revenue in Non-invasive Parenteral Screening Business (2017-2022)
        7.9.5 Agilent Technologies Recent Development
    7.10 BGI Group
        7.10.1 BGI Group Company Details
        7.10.2 BGI Group Business Overview
        7.10.3 BGI Group Non-invasive Parenteral Screening Introduction
        7.10.4 BGI Group Revenue in Non-invasive Parenteral Screening Business (2017-2022)
        7.10.5 BGI Group Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Non-invasive Parenteral Screening Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Non-invasive Parenteral Screening Market Trends
    Table 3. Non-invasive Parenteral Screening Market Drivers
    Table 4. Non-invasive Parenteral Screening Market Challenges
    Table 5. Non-invasive Parenteral Screening Market Restraints
    Table 6. Global Non-invasive Parenteral Screening Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Non-invasive Parenteral Screening Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Non-invasive Parenteral Screening Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Non-invasive Parenteral Screening Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Non-invasive Parenteral Screening Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Non-invasive Parenteral Screening Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Non-invasive Parenteral Screening Revenue Share by Player, 2017-2022
    Table 13. Global Non-invasive Parenteral Screening Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Non-invasive Parenteral Screening by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-invasive Parenteral Screening as of 2021)
    Table 15. Top Players of Non-invasive Parenteral Screening in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Non-invasive Parenteral Screening Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Non-invasive Parenteral Screening Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Non-invasive Parenteral Screening Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Non-invasive Parenteral Screening Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Non-invasive Parenteral Screening Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Non-invasive Parenteral Screening Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Non-invasive Parenteral Screening Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Non-invasive Parenteral Screening Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Non-invasive Parenteral Screening Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Non-invasive Parenteral Screening Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Non-invasive Parenteral Screening Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Non-invasive Parenteral Screening Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Non-invasive Parenteral Screening Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. GE Healthcare Company Details
    Table 31. GE Healthcare Business Overview
    Table 32. GE Healthcare Non-invasive Parenteral Screening Product
    Table 33. GE Healthcare Revenue in Non-invasive Parenteral Screening Business (2017-2022) & (US$ Million)
    Table 34. GE Healthcare Recent Development
    Table 35. Philips Company Details
    Table 36. Philips Business Overview
    Table 37. Philips Non-invasive Parenteral Screening Product
    Table 38. Philips Revenue in Non-invasive Parenteral Screening Business (2017-2022) & (US$ Million)
    Table 39. Philips Recent Development
    Table 40. Illumina Company Details
    Table 41. Illumina Business Overview
    Table 42. Illumina Non-invasive Parenteral Screening Product
    Table 43. Illumina Revenue in Non-invasive Parenteral Screening Business (2017-2022) & (US$ Million)
    Table 44. Illumina Recent Development
    Table 45. Thermo Fisher Scientific Company Details
    Table 46. Thermo Fisher Scientific Business Overview
    Table 47. Thermo Fisher Scientific Non-invasive Parenteral Screening Product
    Table 48. Thermo Fisher Scientific Revenue in Non-invasive Parenteral Screening Business (2017-2022) & (US$ Million)
    Table 49. Thermo Fisher Scientific Recent Development
    Table 50. Roche Company Details
    Table 51. Roche Business Overview
    Table 52. Roche Non-invasive Parenteral Screening Product
    Table 53. Roche Revenue in Non-invasive Parenteral Screening Business (2017-2022) & (US$ Million)
    Table 54. Roche Recent Development
    Table 55. PacBio Company Details
    Table 56. PacBio Business Overview
    Table 57. PacBio Non-invasive Parenteral Screening Product
    Table 58. PacBio Revenue in Non-invasive Parenteral Screening Business (2017-2022) & (US$ Million)
    Table 59. PacBio Recent Development
    Table 60. Perkinelmer Company Details
    Table 61. Perkinelmer Business Overview
    Table 62. Perkinelmer Non-invasive Parenteral Screening Product
    Table 63. Perkinelmer Revenue in Non-invasive Parenteral Screening Business (2017-2022) & (US$ Million)
    Table 64. Perkinelmer Recent Development
    Table 65. Qiagen Company Details
    Table 66. Qiagen Business Overview
    Table 67. Qiagen Non-invasive Parenteral Screening Product
    Table 68. Qiagen Revenue in Non-invasive Parenteral Screening Business (2017-2022) & (US$ Million)
    Table 69. Qiagen Recent Development
    Table 70. Agilent Technologies Company Details
    Table 71. Agilent Technologies Business Overview
    Table 72. Agilent Technologies Non-invasive Parenteral Screening Product
    Table 73. Agilent Technologies Revenue in Non-invasive Parenteral Screening Business (2017-2022) & (US$ Million)
    Table 74. Agilent Technologies Recent Development
    Table 75. BGI Group Company Details
    Table 76. BGI Group Business Overview
    Table 77. BGI Group Non-invasive Parenteral Screening Product
    Table 78. BGI Group Revenue in Non-invasive Parenteral Screening Business (2017-2022) & (US$ Million)
    Table 79. BGI Group Recent Development
    Table 80. Research Programs/Design for This Report
    Table 81. Key Data Information from Secondary Sources
    Table 82. Key Data Information from Primary Sources
List of Figures
    Figure 1. Non-invasive Parenteral Screening Product Picture
    Figure 2. Global Non-invasive Parenteral Screening Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Non-invasive Parenteral Screening Market Size 2017-2028 (US$ Million)
    Figure 4. United States Non-invasive Parenteral Screening Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Non-invasive Parenteral Screening Market Size 2017-2028 (US$ Million)
    Figure 6. United States Non-invasive Parenteral Screening Market Share in Global 2017-2028
    Figure 7. Non-invasive Parenteral Screening Report Years Considered
    Figure 8. Product Picture of Instruments
    Figure 9. Product Picture of Consumables
    Figure 10. Global Non-invasive Parenteral Screening Market Share by Type in 2022 & 2028
    Figure 11. Global Non-invasive Parenteral Screening Market Size by Type (2017-2028) & (US$ Million)
    Figure 12. Global Non-invasive Parenteral Screening Market Share by Type (2017-2028)
    Figure 13. United States Non-invasive Parenteral Screening Market Share by Type in 2022 & 2028
    Figure 14. United States Non-invasive Parenteral Screening Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. United States Non-invasive Parenteral Screening Market Share by Type (2017-2028)
    Figure 16. Product Picture of Diagnostic Laboratories
    Figure 17. Product Picture of Hospitals
    Figure 18. Global Non-invasive Parenteral Screening Market Share by Application in 2022 & 2028
    Figure 19. Global Non-invasive Parenteral Screening Market Size by Application (2017-2028) & (US$ Million)
    Figure 20. Global Non-invasive Parenteral Screening Market Share by Application (2017-2028)
    Figure 21. United States Non-invasive Parenteral Screening Market Share by Application in 2022 & 2028
    Figure 22. United States Non-invasive Parenteral Screening Market Size by Application (2017-2028) & (US$ Million)
    Figure 23. United States Non-invasive Parenteral Screening Market Share by Application (2017-2028)
    Figure 24. North America Non-invasive Parenteral Screening Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 25. U.S. Non-invasive Parenteral Screening Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 26. Canada Non-invasive Parenteral Screening Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 27. Europe Non-invasive Parenteral Screening Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 28. Germany Non-invasive Parenteral Screening Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. France Non-invasive Parenteral Screening Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. U.K. Non-invasive Parenteral Screening Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. Italy Non-invasive Parenteral Screening Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Russia Non-invasive Parenteral Screening Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Non-invasive Parenteral Screening Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 34. China Non-invasive Parenteral Screening Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Japan Non-invasive Parenteral Screening Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. South Korea Non-invasive Parenteral Screening Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. India Non-invasive Parenteral Screening Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Australia Non-invasive Parenteral Screening Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Taiwan Non-invasive Parenteral Screening Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Indonesia Non-invasive Parenteral Screening Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Thailand Non-invasive Parenteral Screening Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Malaysia Non-invasive Parenteral Screening Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Philippines Non-invasive Parenteral Screening Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Latin America Non-invasive Parenteral Screening Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 45. Mexico Non-invasive Parenteral Screening Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Brazil Non-invasive Parenteral Screening Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Argentina Non-invasive Parenteral Screening Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Middle East & Africa Non-invasive Parenteral Screening Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 49. Turkey Non-invasive Parenteral Screening Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Saudi Arabia Non-invasive Parenteral Screening Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. U.A.E Non-invasive Parenteral Screening Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. GE Healthcare Revenue Growth Rate in Non-invasive Parenteral Screening Business (2017-2022)
    Figure 53. Philips Revenue Growth Rate in Non-invasive Parenteral Screening Business (2017-2022)
    Figure 54. Illumina Revenue Growth Rate in Non-invasive Parenteral Screening Business (2017-2022)
    Figure 55. Thermo Fisher Scientific Revenue Growth Rate in Non-invasive Parenteral Screening Business (2017-2022)
    Figure 56. Roche Revenue Growth Rate in Non-invasive Parenteral Screening Business (2017-2022)
    Figure 57. PacBio Revenue Growth Rate in Non-invasive Parenteral Screening Business (2017-2022)
    Figure 58. Perkinelmer Revenue Growth Rate in Non-invasive Parenteral Screening Business (2017-2022)
    Figure 59. Qiagen Revenue Growth Rate in Non-invasive Parenteral Screening Business (2017-2022)
    Figure 60. Agilent Technologies Revenue Growth Rate in Non-invasive Parenteral Screening Business (2017-2022)
    Figure 61. BGI Group Revenue Growth Rate in Non-invasive Parenteral Screening Business (2017-2022)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GE Healthcare
Philips
Illumina
Thermo Fisher Scientific
Roche
PacBio
Perkinelmer
Qiagen
Agilent Technologies
BGI Group
Frequently Asked Questions
Non-invasive Parenteral Screening report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Non-invasive Parenteral Screening report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Non-invasive Parenteral Screening report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports